Clinical Trials Logo
  1. Home
  2. Bone Infection
  3. NCT05883995
  4. Details
NCT05883995 Clinical Trial

Avis-PHAGEinLYON Clinic

Bone Infection Clinical Trial

Official title:
Avis-PHAGEinLYON Clinic

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05883995
Other study ID # 23-5092
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 1, 2023
Est. completion date February 1, 2029

Study information
Verified date May 2023
Source Hospices Civils de Lyon
Contact Tristan FERRY, MD
Phone 0033 4.72.07.11.07
Email Tristan.ferry@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Avis-PHAGEinLYON Clinic study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients referred to the Hospices Civils de Lyon for a medical advice for a phage therapy from 2015 to 2028. The primary objective is to quantify the phage therapy requests received at the Hospices Civils de Lyon. 1500 patients will be included in the study.

Recruitment information / eligibility
Status Recruiting
Enrollment 1500
Est. completion date February 1, 2029
Est. primary completion date February 1, 2028
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - - Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028. - Avis-PHAGEinLYON clinic study information notice provided to the patient Exclusion Criteria: - - Opposition of trial participant

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Phage therapy requests
Quantification of phage therapy requests received at the Hospices Civils de Lyon from 2015 to 2028

Locations
Country Name City State
France Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse Lyon

Sponsors (1)
Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Number of phage therapy requests Number of phage therapy requests received at the Hospices Civils de Lyon from 2015 to 2028 per year and per month. at inclusion
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04563325 - Oral-only Antibiotics for Bone and Joint Infections in Children Phase 4
Active, not recruiting NCT04945434 - Clinical Effectiveness of S53P4 Bioactive Glass in Treatment of Long-bone Chronic Osteomyelitis N/A
Active, not recruiting NCT02814591 - Development of a Non-invasive Assessment of Human Bone Quality Using Spatially Offset Raman Spectroscopy
Recruiting NCT03550911 - Biological Collection From Samples From The Gut Microbiota In Patients Having A Bone Or Joint Infection Treated By A Suppressive Subcutaneous Antibiotherapy With Betalactamine (CARBAMICROBIOTA)
Not yet recruiting NCT04154202 - The Role of NM/CT 870 DR Camera in the Diagnosis of Joint Prosthesis and Tibial Open Reduction and Internal Fixation (ORIF) Complications. N/A
Completed NCT04440631 - Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
Recruiting NCT05753215 - Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection Phase 2
Completed NCT03082066 - Soft Tissue and Bone Diameter in Children and Adults for Intraosseus Access
Completed NCT03403608 - Subcutaneous Suppressive Antibiotic Therapy for Bone and Joint Infections N/A
Completed NCT02335905 - Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children Phase 1/Phase 2
Enrolling by invitation NCT04746001 - Artificial Intelligence in the Diagnosis of Orthopaedic Conditions, Particularly Bone Tumours and Infection
Completed NCT01677000 - Clinical Priority Program-Bone Infection Registry
Completed NCT00974493 - Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J) Phase 4
Recruiting NCT04538053 - BonE and Joint Infections - Simplifying Treatment in Children Trial Phase 4
Completed NCT03945864 - Antimicrobial Synthetic Bone Grafts Phase 1/Phase 2
Completed NCT03426761 - Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Phase 4
Terminated NCT03335592 - Cost of Off-label Antibiotics in Osteoarticular Infections
Not yet recruiting NCT06132347 - Performances of DendrisCHIP®OA in Bone and Joint Infections
Completed NCT05732558 - Augmented Reality Navigation System (Endosight) for the Guidance of Bone Biopsy N/A
Completed NCT05895903 - Alveolar Ridges Expansion Using Osseodensification Versus Screw Expansion Technique N/A